FrancophonIA/ELRC3.0 huggingface dataset:
English: Very rare - Diabetic retinopathy
Maltese: Rari afna - Retinopatija dijabetika
English: Trials have indicated a t½ of about 2-5 hours.
Maltese: Il-provi indikaw t½ ta' madwar 2-5 sig at.
English: Uncommon - Urticaria, rash
Maltese: Mhux komuni - Urtikarja, raxx
English: Chrildren and adolescents
Maltese: Tfal u adolexxenti
English: Novo Nordisk A/S Novo Nordisk A/S Novo Allé Hallas Allé DK-2880 Bagsværd DK-4400 Kalundborg Denmark Denmark
Maltese: Novo Nordisk A/S Novo Nordisk A/S Novo Allé Hallas Allé DK-2880 Bagsværd DK-4400
English: For incompatibilities see section 6.2.
Maltese: G al informazzjoni dwar l-inkompatibilitajiet ara sezzjoni 6.2.
English: INFORMATION IN BRAILLE Velosulin
Maltese: INFORMAZZJONI BIL-BRAILLE Velosulin
English: A clinical trial in a single intensive care unit treating hyperglycaemia (blood glucose above 10 mmol/l) in 204 diabetic and 1344 non-diabetic patients undergoing major surgery showed that normoglycaemia (blood glucose 4.4 - 6.1 mmol/l) induced by intravenous treatment with another fast acting human insulin (Actrapid) reduced mortality by 42% (8% versus 4.6%).
Maltese: Prova klinika f'unità wa da ta' kura intensiva fejn issir il-kura ta' l-ipergli emija (livell ta' glukosju fid-demm og la minn 10 mmol/l) li saret fuq 204 pazjent dijabetiku u 1344 pazjent mhux dijabetiku li kellhom operazzjoni ma uri, uriet li n-normogli emija (livell ta' glukosju fid-demm ta' 4.4 - 6.1 mmol/l) ikkaw ata minn kura fil-vini b'insulina umana o ra li ta dem malajr (Actrapid), naqqset ilmortalita' bi 42% (8% kontra 4.6%).
English: One IU (International Unit) corresponds to 0.035 mg of anhydrous human insulin.
Maltese: UI (Unità Internazzjonali) wa da tikkorrispondi g al 0.035 mg ta' insulina umana anidra.
English: Usually, 40-60% of the total daily dose is given as a continuous basal rate and the remaining 40-60% as boluses divided between the three main meals.
Maltese: Normalment, 40-60% tad-do a totali ta' kuljum ting ata b ala rata ba ali kontinwa u l-bqija 40-60% b ala boluses imqassmin fuq it-tlett ikliet prin ipali.
English: These symptoms are usually of transitory nature.
Maltese: Dawn is-sintomi normalment ikunu ta' natura temporanja.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Insulin human, rDNA (produced by recombinant DNA technology in Saccharomyces cerevisiae).
Maltese: U KWANTITATTIVA Insulina umana, rDNA (mag mula permezz tat-teknolo ija tad-DNA rikombinanti f'Saccharomyces cerevisiae).
English: Isolated spontaneous cases are presented as very rare defined as <1/10,000 including isolated reports.
Maltese: Ka ijiet spontanji i olati huma ppre entati b ala rari afna u definiti b ala <1/10,000, li jinkludu rapporti i olati.
English: Human insulin is reported to be degraded by insulin protease or insulin-degrading enzymes and possibly protein disulfide isomerase.
Maltese: Hu rrappurtat li l-insulina umana ti i degradata mill-protease insulinika jew mill-enzimi degradanti ta' l-insulina u possibbilment mill-proteina disulfide isomerase.
English: zinc chloride, glycerol, metacresol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid and water for injections.
Maltese: zinc chloride, glycerol, metacresol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid u ilma g all-injezzjonijiet
English: This might happen:
Maltese: Dan jista' ji ri:
English: Pack sizes: 1 and 5 vials x 10 ml and a multipack with 5 x (1 x 10 ml) vials.
Maltese: Daqsijiet tal-pakketti: 1 u 5 kunjetti x 10 ml u pakkett multiplu ta' 5 x (1 x 10 ml) kunjetti.
English: Your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (MAOI); beta-blockers; ACE-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; betasympathomimetics; growth hormone; danazol; octreotide or lanreotide.
Maltese: Il- tie a tieg ek g all-insulina tista' tinbidel jekk inti tie u wkoll: inibituri ta' monamine oxidase (MAOI); beta-blokkanti; inibituri ta' l-enzima li tikkonverti l-an jotensin (ACE-inhibitors); acetylsalicylic acid; sterojdi anaboli i; sulphonamides; kontra ettivi orali; tija idi; glukokortikojdi; terapija bl-ormoni tat-tirojdi; beta-simpatomimeti i; ormon tat-tkabbir; danazol; octreotide jew lanreotide.
English: Insulin infusion (CSII):
Maltese: Infu joni ta' l-insulina (CSII):
English: You can keep it in the pump reservoir for 6 days at up to 37°C (close to the body).
Maltese: Tista' ommhom fit-tank tal-pompa g al 6 ijiem f'temperatura sa 37°C (qrib dik tal- isem).
English: Pharmacotherapeutic group: insulins and analogues for injection, fast-acting, insulin (human).
Maltese: Kategorija farmakoterapewtika: insulini u analogi g all-injezzjoni, insulina (umana) li ta dem malajr.
English: Disodium phosphate dihydrate Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injections
Maltese: Disodium phosphate dihydrate Sodium hydroxide (g all-a ustament tal-pH) Hydrochloric acid (g all-a ustament tal-pH) Ilma g all-injezzjonijiet
English: Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol.
Maltese: Konta ettivi orali, tija idi, glukokortikojdi, ormoni tat-tirojde u beta-simpatomimeti i, ormon tattikbir u danazol.
English: Uncommon - Oedema
Maltese: Mhux komuni - Edema
English: The frequencies are defined as: uncommon (≥ <1/100).
Maltese: Il-frekwenzi huma definiti b ala: mhux komuni ( 1/1,000 sa <1/100).
English: The pharmacokinetic profile has been studied in a small number (n=18) of diabetic children (aged 612 years) and adolescents (aged 13-17 years) using another fast-acting human insulin, (Actrapid).
Maltese: Il-profil farmakokinetiku kien studjat f'numru g ir (n=18) ta' tfal dijabeti i (6-12-il sena) u adolexxenti (13-17-il sena) li kienu qed ju aw insulina umana o ra li ta dem malajr, (Actrapid).
English: Do not freeze.
Maltese: Tqala u treddig
English: 1 ml solution contains 100 IU (3.5 mg) of insulin human (rDNA).
Maltese: 1 ml tas-soluzzjoni fiha 100 UI (3.5 mg) ta' insulina umana (rDNA),
English: 1 vial contains 10 ml equivalent to 1000 IU
Maltese: Kunjett fih 10 ml, ekwivalenti g al 1000 UI
English: MARKETING AUTHORISATION NUMBERS EU/1/02/232/001 1 x 10 ml
Maltese: NUMRI TA' L-AWTORIZZAZZJONI G AT-TQEG ID FIS-SUQ EU/1/02/232/001 1 x 10 ml
English: Do not store above 25°C.
Maltese: Ta inx f'temperatura 'l fuq minn 25°C.
English: - The active substance is insulin human made by recombinant biotechnology.
Maltese: - Is-sustanza attiva hi insulina umana mag mula minn bijoteknolo ija rikombinanti.
English: 10 ml glass vial (type 1) closed with a bromobutyl/polyisoprene rubber stopper and a protective tamper-proof cap.
Maltese: Kunjett tal- ie (tip 1) ta' 10 ml mag luq b'tapp tal-gomma ta' bromobutyl/polyisoprene u b'g atu protettiv kontra t-tbag bis.
English: Oral hypoglycaemic agents (OHA), monoamine oxidase inhibitors (MAOI), non-selective betablocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids or sulphonamides.
Maltese: Sustanzi ipogli emi i li jittie du mill- alq (OHA), inibituri ta' monoamine oxidase (MAOI), sustanzi li jimblukkaw ir-ri etturi beta mhux selettivi, inibituri ta' l-enzima li tbiddel angiotensin (ACE), salicylates, alko ol, sterojdi anaboli i jew sulphonamides.
English: Marketing Authorisation Holder and Manufacturer Novo Nordisk A/S
Maltese: Id-detentur ta' l-awtorizzazzjoni g at-tqeg id fis-suq u l-manifattur Novo Nordisk A/S
English: STATEMENT OF ACTIVE SUBSTANCE 1 ml solution contains 100 IU (3.5 mg) of insulin human (rDNA).
Maltese: DIKJARAZZJONI TAS-SUSTANZA ATTIVA 1 ml tas-soluzzjoni fiha 100 UI (3.5 mg) ta' insulina umana (rDNA),
English: In general, when patients are transferred from injection to infusion therapy, it may be advisable to reduce the dosage by initiating the patient at 90% of the previous total daily dosage, with 40% as basal rate and 50% as boluses divided between the three main meals.
Maltese: eneralment, meta l-pazjenti jkunu ttrasferiti minn terapija bl-injezzjoni g al wa da bl-infuzjoni, jista' jkun rakkomandat li tnaqqas id-do a billi l-pazjent tinbdielu l-kura b'90% tad-do a totali ta' qabel ta' kuljum, b'40% b ala r-rata ba ali u 50% b ala boluses imqassmin fuq it-tlett ikliet prin ipali.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION
Maltese: MANIFATTUR TAS-SUSTANZA BIJOLO IKA ATTIVA U
English: Before use: store in a refrigerator (2°C - 8°C).
Maltese: A en fi fri (2°C - 8°C)
English: Solusion for injection or infusion 5 x (1 x 10 ml)
Maltese: Soluzzjoni g all-injezzjoni jew infu joni 5 x (1 x 10 ml)
English: 30 months when stored between 2°C - 8°C.
Maltese: 30 xahar meta jin a en bejn 2°C - 8°C.
English: However, there were differences between age groups in Cmax, stressing the importance of individual dose titration.
Maltese: Madankollu, kien hemm differenzi fis-Cmax bejn il-gruppi ta' l-età, u dan jenfasizza l-importanza tat-titrazzjoni individwali.
English: See also warning in 2 Before you use Velosulin.
Maltese: Ara wkoll it-twissija f'2 Qabel ma tu a Velosulin.
English: Uncommon - Peripheral neuropathy
Maltese: Mhux komuni - Newropatija periferali
English: Insulin in the blood stream has a half-life of a few minutes.
Maltese: L-insulina fi - irkolazzjoni tad-demm g andha half-life ta' ftit minuti.
English: It is supplied in packs of 1 or 5 vials of 10 ml or in a multipack of 5 x (1 x 10 ml) vials.
Maltese: Issibu f'pakketti ta' 1 jew 5 kunjetti ta' 10 ml jew f'pakkett multiplu ta' 5 x (1 x 10 ml) kunjetti.
English: The individual insulin requirement is usually between 0.3 and 1.0 IU/kg/day.
Maltese: Il- tie a individwali ta' linsulina normalment hi ta' bejn 0.3 u 1.0
English: Do not use Velosulin
Maltese: Qabel tu a Velosulin
English: The data are limited but suggest that the pharmacokinetic profile in children and adolescents may be similar to that in adults.
Maltese: Linformazzjoni hi limitata i da tissu erixxi li l-profil farmakokinetiku fit-tfal u fl-adolexxenti jista' jkun simili g al dak fl-adulti.
English: Keep the vial in the outer carton in order to protect from light During use: do not refrigerate or store above 25°C May be kept in an infusion pump at up to 37°C for 6 days
Maltese: Tag mlux fil-fri jew ta nu f'temperatura 'l fuq minn 25°C Jista' jin amm f'pompa ta' l-infu joni f'temperatura sa 37°C g al 6 ijiem
English: Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Maltese: Kontroll gli emiku a jar fit-tul inaqqas ir-riskju tal-progressjoni tar-retinopatija dijabetika.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first suthorisation: 07 October 2002
Maltese: DID TA' L-AWTORIZZAZZJONI Data ta' l-ewwel awtorizzazzjoni: 07 Ottubru 2002
English: Swollen joints.
Maltese: IU/kg/kuljum.
English: Insulin injection:
Maltese: Injezzjoni ta' l-insulina:
English: Uncommon - Lipodystrophy
Maltese: Mhux komuni - Lipodistrofija
English: Medicinal products added to the insulin solution may cause degradation of the insulin, e.g. if the medicinal products contain thiols or sulphites.
Maltese: Il-prodotti medi inali li ji diedu mas-soluzzjoni ta' l-insulina jistg u jikkaw aw id-degradazzjoni ta' l- insulina, e . jekk il-prodotti medi inali jkun fihom thiols jew sulphites.
English: Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement (see sections 4.8 and 4.9).
Maltese: Tista' sse l-ipogli emija jekk id-do a ta' l-insulina tkun g olja wisq meta mqabbla mal- tie a g all-insulina (ara sezzjonijiet 4.8 u 4.9).
English: When Velosulin is administered as a bolus injection onset of action is within ½ hour, reaches a maximum effect within 1.5-3.5 hours and the entire duration of action is approximately 7-8 hours.
Maltese: Meta Velosulin jing ata b ala injezzjoni bolus, jibda ja dem fi mien nofs sieg a, jil aq l-effett massimu fi mien 1.5-3.5 sig at, u l- in totali ta' kemm idum ja dem hu ta' madwar 7-8 sig at.
English: Renal or hepatic impairment may reduce insulin requirement.
Maltese: L-indeboliment renali jew epatiku jista' jnaqqas il- tie a ta' l-insulina.
English: The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Maltese: Is-sinjali ta' twissija ta' ipo jistg u jigu g al g arrieda u jistg u jinkludu: g araq kiesa ; ilda kies a u pallida; u ig ta' ras; ta bit mg a el tal-qalb; t ossok imqalla'; t oss u kbir; tibdil temporanju fil-vista; ng as; g eja mhux tas-soltu u dg jufija; nervo ità jew rog da; t ossok ansju /a; t ossok konfu /a; diffikultà biex tikkon entra.
English: EXP/ During use: use within 6 weeks
Maltese: JIS/ Waqt l-uu: ua fi mien 6 imgat
English: Absorption
Maltese: MANIFATTURA
English: Treatment of diabetes mellitus.
Maltese: Kura ta' dijabete mellitus.
English: Hypersensitivity to the active substance or to any of the excipients (see section 6.1).
Maltese: Sensittività e essiva g as-sustanza attiva jew g al xi sustanzi mhux attivi (ara sezzjoni 6.1).
English: The maximum plasma concentration is reached within 1.5-2.5 hours after subcutaneous administration.
Maltese: Assorbiment Il-kon entrazzjoni massima fil-pla ma tintla aq fi mien 1.5-2.5 sig at wara l-g oti ta t il- ilda.
English: • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional.
Maltese: • Episodji ta' ipogli emija severa, fejn il-pazjent jintilef minn sensih, jistg u ji u kkurati bilglucagon (0.5 sa 1 mg) mog ti fil-muskoli jew ta t il- ilda minn persuna li tkun ir eviet struzzjonijiet xierqa, jew bil-glukosju mog ti ol-vina minn professjonist mediku.
English: SC, IV use
Maltese: Ara l-pariri f'4
English: Solusion for injection or infusion 1 x 10 ml
Maltese: Soluzzjoni g all-injezzjoni jew infu joni 1 x 10 ml
English: Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/loss of consciousness.
Maltese: Sintomi ta' sensittività e essiva eneralizzata jistg u jinkludu raxx eneralizzat tal- ilda, akk, g araq, disturbi gastro-intestinali, edima an jonewrotika, diffikultajiet biex tie u n-nifs, palpitazzjonijiet u tnaqqis fil-pressjoni tad-demm u ass a in/tintilef minn sensik.
English: Octreotide/lanreotide may both decrease and increase insulin requirement.
Maltese: Octreotide/lanreotide jistg u kemm inaqqsu kif ukoll i idu l- tie a ta' l-insulina.
English: This phosphate-buffered soluble insulin is intended for continuous subcutaneous insulin infusion (CSII) in external insulin infusion pumps.
Maltese: Din l-insulina li tin all b'buffer tal-phosphate hi intenzjonata g al infu joni kontinwa ta t il- ilda (continuous subcutaneous insulin infusion - CSII) f'pompi tal-infu joni esterni ta' l-insulina.
English: Velosulin 100 IU/ml solution for injection in a vial Insulin human (rDNA)
Maltese: Velosulin 100 UI/ml soluzzjoni g all-injezzjoni f'kunjett Insulina umana (rDNA)
English: Side effects reported very rarely (in less than 1 patient in 10,000)
Maltese: Effetti sekondarji rrappurtati b'mod rari afna (anqas minn pazjent 1 minn kull 10,000)
English: Dosage
Maltese: MHUX
English: Take special care with Velosulin
Maltese: Tu ax Velosulin
English: Signs of allergy.
Maltese: Sinjali ta' aller ija.
English: Changes in strength, brand (manufacturer), type (fast-, dual-, long-acting insulin etc.), origin (animal, human or analogue insulin) and/or method of manufacture (recombinant DNA versus animal source insulin) may result in a need for a change in dosage.
Maltese: Tibdil fil-qawwa, fil-marka (manifattur), fit-tip (insulina li ta dem malajr, b' ew funzjonijiet, li ta dem fit-tul, e .), fl-ori ini (insulina li ejja mill-annimali, umana jew analoga) u/jew fil-metodu tal-manifattura (insulina tad-DNA rikombinanti, kontra insulina li ejja minn sors ta' l-annimali), jista' jirri ulta fi tie a g al tibdil fid-do a.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/02/232/001-003
Maltese: NUMRU(I) TA' L-AWTORIZZAZZJONI G AT-TQEG ID FIS-SUQ EU/1/02/232/001-003
English: MARKETING AUTHORISATION NUMBERS EU/1/02/232/003
Maltese: NUMRI TA' L-AWTORIZZAZZJONI G AT-TQEG ID FIS-SUQ EU/1/02/232/003
English: Eat a meal or snack containing carbohydrates within 30 minutes of administration.
Maltese: Kul ikla jew ikla afifa li jkun fiha l-karboidrati fi mien 30 minuta mill-injezzjoni.
English: Use in infusion pump
Maltese: KLASSIFIKAZZJONI ENERALI
English: Refraction anomalies may occur upon initiation of insulin therapy.
Maltese: Anomaliji tar-rifrazzjoni jistg u jse u mal-bidu tat-terapija bl-insulina.
English: Very rare - Anaphylactic reactions
Maltese: Rari afna - Reazzjonijiet anafilatti i
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE
Maltese: Isem u indirizz tal-manifattur tas-sustanza bijolo ika attiva
English: To mix Velosulin with long acting insulin
Maltese: • Jekk tieu wisq insulina
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.
Maltese: Informazzjoni li mhix klinika b'Velosulin, mag mula fuq studji konvenzjonali ta' sigurtà farmakolo ika, effett tossiku minn do i ripetuti, effett tossiku fuq il- eni, riskju ta' kan er, effett tossiku fuq is-sistema riproduttiva, ma turi l-ebda periklu spe jali g all-bnedmin.
English: Do not use Velosulin after the expiry date which is stated on the label and the carton.
Maltese: Tu ax Velosulin wara d-data ta' skadenza li tidher fuq it-tikketta u fuq il-kartuna.
English: The patient should read and follow the instructions that accompany the infusion pump and use the correct reservoir and catheter for the pump (see section 6.6).
Maltese: Il-pazjent g andu jaqra u jsegwi l-istruzzjonijiet li ji u mal-pompa ta' l-infu joni u ju a t-tank u lkateter li suppost g all-pompa (ara sezzjoni 6.6).
English: Glucose must also be given intravenously, if the patient does not respond to glucagon within 10 to 15 minutes.
Maltese: Glukosju g andu wkoll jing ata ol-vini jekk il-pazjent ma jirrispondix g al glucagon bejn 10 u 15-il
English: MARKETING AUTHORISATION NUMBER(S) EU/1/02/232/003
Maltese: NUMRU(I) TA' L-AWTORIZZAZZJONI G AT-TQEG ID FIS-SUQ EU/1/02/232/003
English: What Velosulin contains
Maltese: Velosulin 100
English: Pregnancy and breast-feeding
Maltese: TAL-PRODOTT MEDI INALI
English: A number of cleavage (hydrolysis) sites on the human insulin molecule have been proposed; none of the metabolites formed following the cleavage are active.
Maltese: Numru ta' siti tal-cleavage (idrolisi) fuq il-molekula ta' l-insulina umana ew proposti; l-ebda wie ed mill-metaboliti li ffurmaw wara lcleavage ma kienu attivi.
English: However, hypoglycaemia may develop over sequential stages:
Maltese: Fittex parir mediku immedjatament:
English: However, intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy.
Maltese: Madankollu, l-intensifikazzjoni tat-terapija bl-insulina b'titjib f'daqqa tal-kontroll gli emiku, tista' tkun asso jata ma' retinopatija dijabetika li tmur g all-ag ar temporanjament.
English: Name and address of the manufacturers responsible for batch release
Maltese: Isem u indirizz tal-manifatturi responsabbli g all- ru tal-lott
English: If you get a hypo
Maltese: Meta tu a medi ini ohra
English: In type 1 diabetes, untreated hyperglycaemic events eventually lead to diabetic ketoacidosis, which is potentially lethal.
Maltese: F'pazjenti b'dijabete ta' tip 1, avvenimenti ipergli emi i li ma jkunux ikkurati, eventwalment iwasslu g al ketoa idosi dijabetika, li hi potenzjalment fatali.
English: Velosulin vials are for use with insulin syringes with the corresponding unit scale.
Maltese: Velosulin hu insulina li ta dem malajr.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Velosulin 100 IU/ml solution for injection or infusion Insulin human (rDNA)
Maltese: U MNEJN G ANDU JING ATA Velosulin 100 UI/ml soluzzjoni g all-injezzjoni jew infu joni Insulina umana (rDNA)
English: Frequencies of adverse drug reactions from clinical trials that are considered related to fast-acting ≥1/1,000 to human insulin (Actrapid) are listed below.
Maltese: Il-frekwenzi tar-reazzjonijiet avversi tal-medi ina minn provi klini i, li huma kkunsidrati li huma konnessi ma' insulina umana li ta dem malajr (Actrapid) huma elenkati hawn ta t.
English: Painful neuropathy (nerve related pain).
Maltese: Newropatija bl-u ig (u ig marbut man-nervaturi).
English: • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON Medicinal product subject to medical prescription
Maltese: • KUNDIZZJONIJIET JEW RESTRIZZJONIJIET FUQ IL-FORNIMENT U L-U U IMPOSTI FUQ ID-DETENTUR TA' L-AWTORIZZAZZJONI G AT-TQEG ID FIS
English: PARTICULARS TO APPEAR ON THE PACKAGING OUTER WRAPPER LABLE ON MULTIPACKS
Maltese: Dan hu pakkett multiplu u mhux g all-bejg ta' kunjetti individwali
English: This is called acute painful neuropathy and it usually disappears.
Maltese: Din il-kundizzjoni hi msej a newropatija akuta bl-u ig , u normalment tispi a fix-xejn.
English: Alcohol may intensify and prolong the hypoglycaemic effect of insulin.
Maltese: L-alko ol jista' jintensifika u jtawwal l-effetti ipogli emi i ta' l-insulina.
English: Patients whose blood glucose control is greatly improved e.g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia and should be advised accordingly.
Maltese: G alhekk hu rakkomandat li jsir kontroll intensifikat fil-kura ta' nisa tqal li g andhom id-dijabete matul it-tqala kollha, u meta mara tkun qed tippjana li to ro tqila.
English: Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirement.
Maltese: Mard fl-istess mien, spe jalment infezzjonijiet u kundizzjonijiet ta' deni, normalment i idu l- tie a tal-pazjent g all-insulina.
English: indinavir, ritonavir)
Maltese: protease eż. indinavir, ritonavir)
English: 1407 Sofia, Bulgaria Teл.
Maltese: 1407 Sofia, BulgariaTeл.:
English: Str. Livezeni nr. 7A Târgu Mureş 540472 Romania
Maltese: Livezeni nr. 7A Târgu Mureş 540472 Ir-Rumanija
English: Aripiprazole undergoes minimal pre-systemic metabolism.
Maltese: Aripiprazole jgħaddi minn metaboliżmu pre-sistematiku minimu.
English: venlafaxine, St. John's Wort)
Maltese: (bħal fluoxetine, paroxetine, venlafaxine, St John's Wort)
English: Aluminium//Aluminium blister.
Maltese: Folja tal-Aluminju//Aluminju.
English: 10 tablets 14 tablets 16 tablets 28 tablets 30 tablets 35 tablets 56 tablets 70 tablets
Maltese: 10 pilloli 14-il pillola 16-il pillola 28 pillola 30 pillola 35 pillola 56 pillola 70 pillola
English: Increased Alanine Aminotransferase (ALT) Increased Aspartate Aminotransferase (AST) Increased Gamma Glutamyl Transferase (GGT) Increased alkaline phosphatase
Maltese: Żieda fl-aspartate aminotransferase (AST) Żieda fil-gamma glutamyl transferase (GGT) Żieda fl-alkaline phosphatase
English: [Only Carton for bottle:] PC: {number} SN: {number} NN: {number}
Maltese: [Il-Kartuna għal flixkun biss:] PC:
English: Calea Floreasca nr. 169A, Cladirea A, etaj 1, sector 1, Bucure ti e-mail: upit.croatia@sandoz.com
Maltese: Calea Floreasca nr. 169A, Cladirea A, etaj 1, sector 1, Bucure ti
English: 14 x 1 tablets 28 x 1 tablets 49 x 1 tablets 56 x 1 tablets 98 x 1 tablets
Maltese: 14 x 1 pillola 28 x 1 pillola 49 x 1 pillola 56 x 1 pillola 98 x 1 pillola